Vanguard Group’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$20.4M Sell
16,981,738
-243,512
-1% -$292K ﹤0.01% 2549
2025
Q1
$18.6M Buy
17,225,250
+69,104
+0.4% +$74.6K ﹤0.01% 2535
2024
Q4
$30M Sell
17,156,146
-135,946
-0.8% -$238K ﹤0.01% 2393
2024
Q3
$33.4M Buy
17,292,092
+1,288,934
+8% +$2.49M ﹤0.01% 2358
2024
Q2
$28.3M Buy
16,003,158
+2,969,115
+23% +$5.26M ﹤0.01% 2389
2024
Q1
$35.3M Buy
13,034,043
+8,900,104
+215% +$24.1M ﹤0.01% 2321
2023
Q4
$9.14M Buy
4,133,939
+159,413
+4% +$352K ﹤0.01% 2998
2023
Q3
$11.5M Buy
3,974,526
+31,636
+0.8% +$91.7K ﹤0.01% 2807
2023
Q2
$7.61M Sell
3,942,890
-13,078
-0.3% -$25.2K ﹤0.01% 3104
2023
Q1
$7.71M Hold
3,955,968
﹤0.01% 3083
2022
Q4
$4.63M Buy
3,955,968
+1,614
+0% +$1.89K ﹤0.01% 3341
2022
Q3
$4.35M Buy
3,954,354
+396,800
+11% +$436K ﹤0.01% 3398
2022
Q2
$5.69M Sell
3,557,554
-359,278
-9% -$575K ﹤0.01% 3308
2022
Q1
$14.1M Buy
3,916,832
+49,161
+1% +$176K ﹤0.01% 2968
2021
Q4
$15.2M Buy
3,867,671
+280,792
+8% +$1.1M ﹤0.01% 2982
2021
Q3
$23.6M Sell
3,586,879
-76,966
-2% -$507K ﹤0.01% 2769
2021
Q2
$22.6M Sell
3,663,845
-71,225
-2% -$439K ﹤0.01% 2775
2021
Q1
$16.9M Buy
3,735,070
+258,760
+7% +$1.17M ﹤0.01% 2870
2020
Q4
$20.9M Sell
3,476,310
-52,965
-2% -$318K ﹤0.01% 2612
2020
Q3
$26.2M Sell
3,529,275
-402,307
-10% -$2.99M ﹤0.01% 2324
2020
Q2
$15.8M Sell
3,931,582
-528,106
-12% -$2.12M ﹤0.01% 2541
2020
Q1
$11.3M Buy
4,459,688
+49,912
+1% +$127K ﹤0.01% 2562
2019
Q4
$15.3M Buy
4,409,776
+6,466
+0.1% +$22.5K ﹤0.01% 2653
2019
Q3
$20.4M Buy
4,403,310
+656,502
+18% +$3.04M ﹤0.01% 2487
2019
Q2
$46.2M Buy
3,746,808
+1,711,187
+84% +$21.1M ﹤0.01% 2143
2019
Q1
$27.1M Buy
2,035,621
+240,425
+13% +$3.2M ﹤0.01% 2370
2018
Q4
$15.5M Buy
1,795,196
+384,670
+27% +$3.32M ﹤0.01% 2560
2018
Q3
$10.6M Buy
1,410,526
+121,815
+9% +$912K ﹤0.01% 2889
2018
Q2
$7.68M Sell
1,288,711
-48,623
-4% -$290K ﹤0.01% 3032
2018
Q1
$7.81M Buy
1,337,334
+12,545
+0.9% +$73.3K ﹤0.01% 2949
2017
Q4
$7.8M Buy
1,324,789
+138,716
+12% +$817K ﹤0.01% 2943
2017
Q3
$5.98M Buy
1,186,073
+534,196
+82% +$2.69M ﹤0.01% 3045
2017
Q2
$2.63M Sell
651,877
-530,006
-45% -$2.14M ﹤0.01% 3298
2017
Q1
$6.73M Buy
1,181,883
+19,669
+2% +$112K ﹤0.01% 2940
2016
Q4
$8.46M Buy
1,162,214
+29,771
+3% +$217K ﹤0.01% 2825
2016
Q3
$9.07M Buy
1,132,443
+49,259
+5% +$395K ﹤0.01% 2736
2016
Q2
$9.78M Buy
1,083,184
+24,638
+2% +$222K ﹤0.01% 2660
2016
Q1
$8.54M Buy
1,058,546
+74,139
+8% +$598K ﹤0.01% 2696
2015
Q4
$10.6M Sell
984,407
-13,454
-1% -$145K ﹤0.01% 2600
2015
Q3
$8.09M Buy
997,861
+20,931
+2% +$170K ﹤0.01% 2715
2015
Q2
$23.6M Buy
976,930
+29,381
+3% +$711K ﹤0.01% 2279
2015
Q1
$39.9M Buy
947,549
+55,790
+6% +$2.35M ﹤0.01% 2021
2014
Q4
$30.1M Buy
891,759
+37,284
+4% +$1.26M ﹤0.01% 2077
2014
Q3
$20.9M Buy
854,475
+6,612
+0.8% +$162K ﹤0.01% 2184
2014
Q2
$24.9M Buy
847,863
+46,105
+6% +$1.36M ﹤0.01% 2135
2014
Q1
$35.3M Buy
801,758
+122,592
+18% +$5.4M ﹤0.01% 1983
2013
Q4
$26M Buy
679,166
+106,191
+19% +$4.07M ﹤0.01% 2073
2013
Q3
$12.6M Buy
572,975
+47,306
+9% +$1.04M ﹤0.01% 2288
2013
Q2
$9.18M Buy
+525,669
New +$9.18M ﹤0.01% 2363